Myeloma Canada annual publications

Home | About us | Myeloma Canada annual publications
Close up of a red gerbera daisy on a white background

Where we’ve been and where we’re going

Get to know Myeloma Canada and the work we do.

Year in review

Thanks to the support of our community and donors, we have realized many outstanding accomplishments over the years. The outlook for individuals living with myeloma has never been brighter. Select the Year in Review of your choice to read about our milestones and the advancements made in myeloma.

Impact reports

We have never been closer to finding a cure for myeloma. These are exciting times in research, and Myeloma Canada is proud to be investing in essential Canadian myeloma research that is improving and extending life for Canadians with this challenging disease.

In 2024 alone, our organization contributed an unprecedented $1.45M in Canadian myeloma science and research projects. This record-breaking investment would not be possible without the generous support and outstanding commitment of our exceptional donors, partners, interested parties, volunteers and staff.  Through our important collaborations and partnerships, we are able to deepen our impact and do more for Canadians affected by myeloma. We invite you to read our 2024 research and science impact report for more information on the projects in which we invested. Together, we will continue to be relentless in our pursuit of a life uninterrupted by myeloma.

Financial reports

Thank you for putting myeloma on the map.

Thanks to the unwavering support of our donors and stakeholders, we are able to pursue our mission and ensure that the important voice of the Canadian myeloma community is heard.

Your donation has a lasting impact on the outcomes of Canadians impacted by myeloma. Our activities range from providing educational resources, to leading advocacy initiatives promoting access to new therapies, to creating a unique national research platform that advances scientific knowledge through collaboration and knowledge sharing.

For more detail, please refer to the Myeloma Canada T3010 Registered Charity Information Return.